Carter BloodCare frequently receives questions about statistics, positions on blood donation and the constant need for a safe and sufficient blood supply.

In addition to those below provided by Carter BloodCare, a wide variety of statements from America’s Blood Centers are also available to the public.

Easy messages to use when talking about blood donation:

  • Each blood donation saves three lives.
  • More than 1,000 donors are needed each day to keep blood on the shelves of hospitals in North, Central and East Texas.
  • Six hundred to 800 patients each day could require a blood transfusion. Many will require more than one unit of blood or blood products.
  • One in seven patients admitted to a hospital could receive a blood transfusion.  
  • There is no substitute for human blood. Thus, there is no substitute for blood donors.
  • Regularly scheduled blood donations assure there is already blood on the shelves during a disaster/crisis.
  • Make a blood donation by setting up an appointment today.
  • You may call or text Carter BloodCare at 800-366-2834.
  • Arrange to host a blood drive by emailing


19 August 2021

Frequently Asked Questions with Convalescent Plasma (CCP) Use On Rise

Carter BloodCare continues to serve hospital patients suffering with COVID-19 by supplying convalescent plasma (CCP)when ordered, thanks to generous volunteer donors. The FDA has very specific criteria for which donors may be able to donate CCP. If in doubt, schedule an appointment to donate blood.

13 April 2020

Change in Donor Eligibility Rules Are Coming

On April 2, 2020, the Food and Drug Administration (FDA), which sets guidelines for blood donor eligibility in the United States, announced new guidelines. These new rules will allow many individuals, previously not eligible to give blood, to start donating. Although the changes are allowed by FDA to be effective immediately, blood centers such as Carter BloodCare need time to write procedures, modify their computer systems, and train their staff on how to implement these changes safely. 

Here at Carter BloodCare we are very excited about these changes, and are working on implementing them as soon as we possibly can, but it will take several weeks (possibly even months) to get them in place.

31 March 2020

A Statement from Carter BloodCare on Convalescent Plasma

Carter BloodCare is working with doctors and hospitals to facilitate the collection of convalescent plasma under the U.S. Food and Drug Administration’s (FDA) Emergency Investigational New Drug (eIND) guidance. The FDA’s web site outlines the protocols for physicians who want to participate in the Investigational COVID-19 Convalescent Plasma - Emergency INDs.

12 March 2020

A Message from President and CEO Dr. Merlyn Sayers

Blood donation remains safe. The first line of protection for the blood supply is the routine health screening of donors. This includes our asking if you are healthy and feeling well on the day of donation. If you have any symptoms of illness, including cold or flu, you should not present to give blood. Blood donors are routinely screened for temperature, pulse rate, blood pressure and hemoglobin. Carter BloodCare encourages all eligible blood donors to make and keep appointments; and for sponsors to continue hosting blood drives.

06 March 2020

Carter BloodCare remains vigilant during evolving COVID-19 outbreak

Carter BloodCare recognizes that there are concerns surrounding the COVID-19 outbreak. As your community blood center, be reassured that we are closely monitoring disease progression. We have daily communications with AABB, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control (CDC). The blood banking community members also remain in close contact with each other about best practices. Carter BloodCare’s mission is at the heart of what we do – saving lives by making transfusion possible.

29 March 2018

Facts about Sickle Cell Disease

Sickle cell disease (SCD) is an inherited blood disorder and is associated with stroke, debilitating pain episodes, severe infections and even death. One in 500 members of the African American community has SCD and many of them are children. Frequent and chronic blood transfusions can treat and relieve pain crises and other symptoms of SCD. Chronically transfused patients often require blood from donors of similar race and ethnicity, to receive the most benefit from the transfusion. The only cure for SCD is a bone marrow transplant and not all patients are candidates for that procedure.

29 July 2016

Statement From Carter BloodCare Concerning Zika Virus

Carter BloodCare is closely monitoring the fluid developments in the state of Florida, concerning the Zika virus. Our staff receives daily updates on newly announced Zika-risk areas. Added to the list now, are Broward and Miami-Dade counties in Florida. This is part of the pre-donation screening process.

14 November 2015

Local Response to Paris Attacks

DALLAS/FORT WORTH, Texas (November 14, 2015) – Carter BloodCare joins with our larger community around the world in extending our heartfelt concerns toward the people of France, in the wake of Friday’s attacks on Paris. In times such as these, many of us want to help and that sometimes means giving blood.